Literature DB >> 21054277

Anticancer activity of the ascidian polyclinum indicum against cervical cancer cells (HeLa) mediated through apoptosis induction.

Rajaian Pusphabai Rajesh1, Maniramakrishnan Santhana Ramasamy, Annappan Murugan.   

Abstract

The cytotoxicity-based chemotherapy treatment for cancer has significant side effects. Therefore, anticancer research is concentrated on identifying an effective drug with minimal side effects. The methanol extract of ascidian Polyclinum indicum and its column fraction PI-8 showed cytotoxicity against cervical cancer cells (HeLa) with an IC₅₀ of 77.5 µg/mL and 1.12 µg/mL. Hoechst staining with PI-8 treated cells portrayed the apoptotic events in drug-induced apoptosis. The PI-8 markedly arrested G₂/M and S phases in cell cycle. The occurrence of a second population of apoptotic cells in the range of lower Forward Scatter (FSC) and higher Side Scatter (SSC) compared to control cells indicated the characteristic feature of the cells dying of apoptosis. DNA fragmentation has established the apoptotic event. The study emphasized the fraction PI-8 of P. indicum as a potential lead compound for apoptosis targeted anticancer drugs. The molecular mechanism and chemotherapeutic potential of the fraction PI-8 needs further investigation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21054277     DOI: 10.2174/157340610793564009

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  2 in total

1.  Patterns of chemical diversity in the marine ascidian Phallusia spp.: anti-tumor activity and metabolic pathway inhibiting steroid biosynthesis.

Authors:  Satheesh Kumar Palanisamy; Velusamy Arumugam; Magesh D Peter; Umamaheswari Sundaresan
Journal:  3 Biotech       Date:  2018-05-10       Impact factor: 2.406

2.  Metabolite profiling of ascidian Styela plicata using LC-MS with multivariate statistical analysis and their antitumor activity.

Authors:  Satheesh Kumar Palanisamy; Daniela Trisciuoglio; Clemens Zwergel; Donatella Del Bufalo; Antonello Mai
Journal:  J Enzyme Inhib Med Chem       Date:  2017-12       Impact factor: 5.051

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.